Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Normothermic Machine Perfusion Market Value Growth And Long-Term Outlook
The normothermic machine perfusion market has expanded swiftly in recent years. Its value is anticipated to rise from $1.48 billion in 2025 to $1.72 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.2%. Historically, the market’s expansion can be linked to factors such as restricted organ preservation technologies, a reliance on cold storage techniques, a scarcity of transplantable organs, a rise in organ transplant procedures, and the initial adoption of stationary perfusion machines.
The normothermic machine perfusion market is anticipated to experience substantial expansion over the next few years. It is forecast to achieve a size of $3.12 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.0%. This growth during the forecast period is attributable to the emergence of portable and battery-operated machines, innovations in mechanical circulation and oxygenation technologies, the increasing global demand for organ transplantation, the integration of smart monitoring systems, and the expanding research and development efforts in organ preservation. Notable trends in the forecast period include the increasing adoption of portable normothermic machines, a heightened focus on organ viability and prolonged preservation, the integration of advanced monitoring and oxygenation technologies, the expansion of organ transplantation programs, and a growing application in research and development.
Get A Free Sample Report With In-Depth Market Insights:
Normothermic Machine Perfusion Market Development Factors: What’s Supporting Demand?
The anticipated expansion of the normothermic machine perfusion market is linked to the rising need for organ transplantation in the future. Organ transplantation is defined as the surgical replacement of a diseased or failing organ with a healthy counterpart from a donor. The surge in organ transplantation procedures stems from the growing incidence of end-stage organ failure, a consequence of chronic illnesses, alongside advancements in surgical methods and immunosuppressive therapies. Within organ transplantation, normothermic machine perfusion plays a crucial role in safeguarding and revitalizing donor organs by keeping them at physiological temperature with oxygenated blood or a suitable perfusate until the surgical transplant. For example, data released by the U.S. Department of Health & Human Services, a US-based government department, in January 2024 indicated that 46,632 organ transplants were carried out in 2023, utilizing both living and deceased donors, representing an 8.7% increase over the figures from 2022. Consequently, the escalating demand for organ transplantation is a primary factor fueling the expansion of the normothermic machine perfusion market.
Normothermic Machine Perfusion Market Segment Outlook: Which Categories Are Growing Fastest?
The normothermic machine perfusion market covered in this report is segmented –
1) By Product Type: Portable Normothermic Machine, Stationary Normothermic Machine
2) By Technology: Mechanical Circulation Technology, Oxygenation Technology, Monitoring Technology
3) By Application: Organ Preservation, Organ Transplantation, Research And Development
4) By End-User: Hospitals And Ambulatory Surgery Centers (ASCs), Specialty Clinics, Other End-Users
Subsegments:
1) By Portable Normothermic Machine: Compact Portable, Battery-Operated Portable Machines, Transport-Friendly Portable Units
2) By Stationary Normothermic Machine: In-Hospital Stationary Machines, Modular Stationary Systems, Advanced Fixed-Location Units
Normothermic Machine Perfusion Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the normothermic machine perfusion market are concentrating on establishing advanced research facilities to accelerate innovation, enhance technologies for organ preservation, and improve results for transplant recipients. Expanding facilities in this domain boosts capacity for organ preservation, research endeavors, and clinical applications, which in turn improves transplant outcomes and the availability of organs. For example, in May 2024, OrganOx Ltd., a medical equipment manufacturing firm from the UK, opened an 18,000 sq. ft. global research and development and production facility in Oxford. This expansion aims to foster innovation and partnerships, following the worldwide success of its metra device in enhancing liver transplant outcomes. The establishment of this facility conveys confidence in advancing scientific and clinical innovation through technological means to provide superior treatment for organ failure.
Normothermic Machine Perfusion Market Leading Players And Competitive Positioning
Major companies operating in the normothermic machine perfusion market are TransMedics Inc., OrganOx Limited, XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., Lifeline Scientific Inc., LifePort Inc., XENIOS AG, Lung Bioengineering Inc., Waters Medical Systems LLC, Organ Assist B.V., Preservation Solutions Inc., Perfusix AB, Fluent Medical Inc., HemoTherapeutics Inc., Revivicor Inc., Transplant Solutions Inc., BioMedica Diagnostics (Organ Perfusion Division), Advanced Perfusion Systems Inc., Organ Preservation Alliance Technologies, NormaTech Medical Systems
View The Full Normothermic Machine Perfusion Market Report:
Normothermic Machine Perfusion Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the normothermic machine perfusion market in 2025. The regions covered in the normothermic machine perfusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
